united therapeutics glp-1 receptor agonist Oral GLP-1-Based in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Agonists For Obesity In

Given the tolerability of exenatide and its direct and early effect on ICP, it may be beneficial in other conditions such as hydrocephalus, traumatic brain injury, raised ICP in stroke and meningitis and space flightassociated neuro-ocular syndrome

Masson, A

doi: 10.1161/CIRCULATIONAHA.122.059595

Leone-Bay A, Grant M, Greene S, Stowell G, Daniels S, Smithson A, et al

The sensitivity analysis excluding one trial with a short duration and one trial that recruited participants on background insulin therapy yielded similar results and reduced statistical heterogeneity

its about promoting long-term health and weight management